April 2024
1. CHEN L, Xing Y, Zhang Y, Xie J, et al
   Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
   PLoS Med. 2024;21:e1004374.
   

   >> Share

   
   March 2024
2. EMANI S, Alves K, Alves LC, da Silva DA, et al
   Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
   PLoS Med. 2024;21:e1004361.
   

   >> Share

   
   February 2024
3. SEMITALA FC, Kadota JL, Musinguzi A, Welishe F, et al
   Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
   PLoS Med. 2024;21:e1004356.
   

   >> Share

   
   November 2023
4. GALILEYA LT, Wasmann RE, Chabala C, Rabie H, et al
   Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
   PLoS Med. 2023;20:e1004303.
   

   >> Share

   
   October 2023
5. NARAYAN A, Salindri AD, Keshavjee S, Muyoyeta M, et al
   Prioritizing persons deprived of liberty in global guidelines for tuberculosis preventive treatment.
   PLoS Med. 2023;20:e1004288.
   

   >> Share

   
   September 2023
6. MAFIRAKUREVA N, Mukherjee S, de Souza M, Kelly-Cirino C, et al
   Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
   PLoS Med. 2023;20:e1004285.
   

   >> Share

   
   
7. KLINKENBERG E, Floyd S, Shanaube K, Mureithi L, et al
   Tuberculosis prevalence after 4 years of population-wide systematic TB symptom screening and universal testing and treatment for HIV in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: A cross-sectional survey (TREATS).
   PLoS Med. 2023;20:e1004278.
   

   >> Share

   
   July 2023
8. PORTNOY A, Arcand JL, Clark RA, Weerasuriya CK, et al
   The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
   PLoS Med. 2023;20:e1004252.
   

   >> Share

   
   June 2023
9. DORVIL N, Rivera VR, Riviere C, Berman R, et al
   Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti.
   PLoS Med. 2023;20:e1004246.
   

   >> Share

   
   May 2023
10. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    

    >> Share

    
    
11. BALIASHVILI D, Blumberg HM, Gandhi NR, Averhoff F, et al
    Hepatitis C care cascade among patients with and without tuberculosis: Nationwide observational cohort study in the country of Georgia, 2015-2020.
    PLoS Med. 2023;20:e1004121.
    

    >> Share

    
    January 2023
12. MARLEY G, Zou X, Nie J, Cheng W, et al
    Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
    PLoS Med. 2023;20:e1004091.
    

    >> Share

    
    
13. PORTNOY A, Clark RA, Quaife M, Weerasuriya CK, et al
    The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study.
    PLoS Med. 2023;20:e1004155.
    

    >> Share

    
    
14. WAHEDI K, Zenner D, Flores S, Bozorgmehr K, et al
    Mandatory, voluntary, repetitive, or one-off post-migration follow-up for tuberculosis prevention and control: A systematic review.
    PLoS Med. 2023;20:e1004030.
    

    >> Share

    
    June 2022
15. NSENGIYUMVA NP, Campbell JR, Oxlade O, Vesga JF, et al
    Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
    PLoS Med. 2022;19:e1004032.
    

    >> Share

    
    March 2022
16. FOSTER N, Nguyen HV, Nguyen NV, Nguyen HB, et al
    Social determinants of the changing tuberculosis prevalence in Viet Nam: Analysis of population-level cross-sectional studies.
    PLoS Med. 2022;19:e1003935.
    

    >> Share

    
    February 2022
17. YANG C, Sobkowiak B, Naidu V, Codreanu A, et al
    Phylogeography and transmission of M. tuberculosis in Moldova: A prospective genomic analysis.
    PLoS Med. 2022;19:e1003933.
    

    >> Share

    
    January 2022
18. FOO C, Shrestha P, Wang L, Du Q, et al
    Integrating tuberculosis and noncommunicable diseases care in low- and middle-income countries (LMICs): A systematic review.
    PLoS Med. 2022;19:e1003899.
    

    >> Share

    
    
19. RODI P, Obermeyer W, Pablos-Mendez A, Gori A, et al
    Political rationale, aims, and outcomes of health-related high-level meetings and special sessions at the UN General Assembly: A policy research observational study.
    PLoS Med. 2022;19:e1003873.
    

    >> Share

    
    December 2021
20. SEMITALA FC, Kadota JL, Musinguzi A, Nabunje J, et al
    Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
    PLoS Med. 2021;18:e1003875.
    

    >> Share

    
    September 2021
21. MACPHERSON P, Webb EL, Kamchedzera W, Joekes E, et al
    Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003752.
    

    >> Share

    
    
22. BASTOS ML, Melnychuk L, Campbell JR, Oxlade O, et al
    The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003703.
    

    >> Share

    
    
23. AULD AF, Kerkhoff AD, Hanifa Y, Wood R, et al
    Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    PLoS Med. 2021;18:e1003739.
    

    >> Share

    
    
24. UPPAL A, Rahman S, Campbell JR, Oxlade O, et al
    Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003712.
    

    >> Share

    
    
25. YANES-LANE M, Ortiz-Brizuela E, Campbell JR, Benedetti A, et al
    Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    PLoS Med. 2021;18:e1003738.
    

    >> Share

    
    
26. OXLADE O, Rochon H, Campbell JR, Menzies D, et al
    Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
    PLoS Med. 2021;18:e1003702.
    

    >> Share

    
    July 2021
27. YU S, Sohn H, Kim HY, Kim H, et al
    Evaluating the impact of the nationwide public-private mix (PPM) program for tuberculosis under National Health Insurance in South Korea: A difference in differences analysis.
    PLoS Med. 2021;18:e1003717.
    

    >> Share

    
    May 2021
28. CATTAMANCHI A, Crowder R, Kityamuwesi A, Kiwanuka N, et al
    Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
    PLoS Med. 2021;18:e1003628.
    

    >> Share

    
    April 2021
29. CALDERWOOD CJ, Wilson JP, Fielding KL, Harris RC, et al
    Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003566.
    

    >> Share

    
    January 2021
30. DORJEE K, Topgyal S, Tsewang T, Tsundue T, et al
    Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment.
    PLoS Med. 2021;18:e1003502.
    

    >> Share

    
    December 2020
31. CILLONI L, Kranzer K, Stagg HR, Arinaminpathy N, et al
    Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis.
    PLoS Med. 2020;17:e1003456.
    

    >> Share

    
    
32. RICKS S, Denkinger CM, Schumacher SG, Hallett TB, et al
    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    PLoS Med. 2020;17:e1003466.
    

    >> Share

    
    November 2020
33. BAIK Y, Rickman HM, Hanrahan CF, Mmolawa L, et al
    A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    PLoS Med. 2020;17:e1003420.
    

    >> Share

    
    October 2020
34. KAVANAGH MM, Gostin LO, Stephens J
    Tuberculosis, human rights, and law reform: Addressing the lack of progress in the global tuberculosis response.
    PLoS Med. 2020;17:e1003324.
    

    >> Share

    
    September 2020
35. ABDULLAHI SA, Smelyanskaya M, John S, Adamu HI, et al
    Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
    PLoS Med. 2020;17:e1003218.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share